T1	Participants 53 141	young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring.
T2	Participants 402 440	Bologna University School of Medicine.
T3	Participants 452 508	Thirty-seven women with polycystic ovary syndrome (PCOS)
